Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Pfizer Inc (PFE)

Pfizer Inc (PFE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 296,704,192
  • Shares Outstanding, K 5,610,896
  • Annual Sales, $ 81,288 M
  • Annual Income, $ 21,980 M
  • 60-Month Beta 0.76
  • Price/Sales 3.62
  • Price/Cash Flow 9.75
  • Price/Book 3.61
Trade PFE with:

Options Overview Details

View History
  • Implied Volatility 28.55% ( -0.05%)
  • Historical Volatility 26.39%
  • IV Percentile 47%
  • IV Rank 49.65%
  • IV High 40.61% on 02/07/22
  • IV Low 16.65% on 06/11/21
  • Put/Call Vol Ratio 0.53
  • Today's Volume 44,820
  • Volume Avg (30-Day) 43,593
  • Put/Call OI Ratio 1.03
  • Today's Open Interest 1,836,897
  • Open Int (30-Day) 1,909,126

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate 2.02
  • Number of Estimates 4
  • High Estimate 2.59
  • Low Estimate 1.54
  • Prior Year 1.07
  • Growth Rate Est. (year over year) +88.79%

Price Performance

See More
Period Period Low Period High Performance
1-Month
47.46 +13.17%
on 05/02/22
54.05 -0.63%
on 05/25/22
+4.76 (+9.72%)
since 04/25/22
3-Month
45.44 +18.20%
on 03/01/22
56.32 -4.63%
on 04/11/22
+5.99 (+12.55%)
since 02/25/22
52-Week
38.47 +39.60%
on 06/08/21
61.71 -12.96%
on 12/20/21
+14.38 (+36.56%)
since 05/25/21

Most Recent Stories

More News
Davos updates | VW: Supply chain woes ease; orders backed up

DAVOS, Switzerland (AP) — Executives with German automaker Volkswagen say at the World Economic Forum meeting in Davos that supply chain problems exacerbated by the Russia-Ukraine war are easing but...

$SPX : 3,978.73 (+0.95%)
$DOWI : 32,120.28 (+0.60%)
$IUXX : 11,943.93 (+1.48%)
CRM : 159.65 (+1.73%)
GOOGL : 2,116.10 (-0.16%)
PFE : 53.71 (+0.56%)
Pfizer to offer low-cost medicines, vaccines to poor nations

Pfizer said Wednesday that it will provide nearly two dozen products, including its top-selling and treatment, at not-for-profit prices in some of the world’s poorest countries.

$SPX : 3,978.73 (+0.95%)
$DOWI : 32,120.28 (+0.60%)
$IUXX : 11,943.93 (+1.48%)
PFE : 53.71 (+0.56%)
How Vaccine Cash Could Fuel Pfizer's Future Growth

The drugmaker has a bold strategy to transform itself by 2030.

PFE : 53.71 (+0.56%)
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the Bernstein 38th Annual Strategic...

PFE : 53.71 (+0.56%)
3 Unstoppable Investments Everyone Needs in Their Portfolio

It's a bold word to describe them, but some companies really are in businesses bigger than any economic headwind.

PFE : 53.71 (+0.56%)
MRK : 93.75 (-0.94%)
PG : 145.21 (-1.64%)
MSFT : 262.52 (+1.12%)
Pfizer (PFE) Reports More Positive Data From Etrasimod Study

Pfizer (PFE) states that data from the ELEVATE 12 and ELEVATE 52 studies will form the basis of the regulatory submissions on etrasimod expected later this year

BMY : 77.24 (+0.14%)
PFE : 53.71 (+0.56%)
ALKS : 28.85 (+1.76%)
SESN : 0.5045 (-3.17%)
Pfizer Launches ‘An Accord for a Healthier World’ to Improve Health Equity for 1.2 Billion People Living in 45 Lower-Income Countries

Pfizer Inc. (NYSE: PFE) today launched ‘An Accord for a Healthier World.’ This groundbreaking initiative aims to provide all of Pfizer’s patented, high-quality medicines and vaccines available in...

PFE : 53.71 (+0.56%)
China's bet on homegrown mRNA vaccines holds back nation

TAIPEI, Taiwan (AP) — China is trying to navigate its biggest coronavirus outbreak without a tool it could have adopted many months ago, the kind of vaccines that have proven to offer the best protection...

PFE : 53.71 (+0.56%)
AstraZeneca (AZN) Gets EU Nod for COVID-19 Booster Shot

AstraZeneca's (AZN) third/booster dose of its COVID-19 vaccine gets authorized in Europe for use in adults, both for homologous and heterologous use.

AZN : 66.81 (+0.24%)
PFE : 53.71 (+0.56%)
MRNA : 130.85 (-0.92%)
BNTX : 154.67 (+0.11%)
Ocugen (OCGN) Covaxin Studies Clinical Hold Lifted by FDA

Ocugen (OCGN) gets respite after the FDA lifts the clinical hold on the company's phase II/III study, OCU-002, for Covaxin (BBV152).

PFE : 53.71 (+0.56%)
MRNA : 130.85 (-0.92%)
OCGN : 2.17 (+4.33%)
BNTX : 154.67 (+0.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare...

See More

Key Turning Points

3rd Resistance Point 55.17
2nd Resistance Point 54.61
1st Resistance Point 54.16
Last Price 53.71
1st Support Level 53.15
2nd Support Level 52.59
3rd Support Level 52.14

See More

52-Week High 61.71
Last Price 53.71
Fibonacci 61.8% 52.83
Fibonacci 50% 50.09
Fibonacci 38.2% 47.35
52-Week Low 38.47

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar